LLY

1,050.93

+2.96%↑

JNJ

248.43

+2.06%↑

ABBV

231.99

+3.33%↑

NVS

168.32

+1.89%↑

MRK

123.72

+3.77%↑

LLY

1,050.93

+2.96%↑

JNJ

248.43

+2.06%↑

ABBV

231.99

+3.33%↑

NVS

168.32

+1.89%↑

MRK

123.72

+3.77%↑

LLY

1,050.93

+2.96%↑

JNJ

248.43

+2.06%↑

ABBV

231.99

+3.33%↑

NVS

168.32

+1.89%↑

MRK

123.72

+3.77%↑

LLY

1,050.93

+2.96%↑

JNJ

248.43

+2.06%↑

ABBV

231.99

+3.33%↑

NVS

168.32

+1.89%↑

MRK

123.72

+3.77%↑

LLY

1,050.93

+2.96%↑

JNJ

248.43

+2.06%↑

ABBV

231.99

+3.33%↑

NVS

168.32

+1.89%↑

MRK

123.72

+3.77%↑

Home・Akcijų sąrašas・Celldex Therapeutics Inc

Celldex Therapeutics Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

29.88 -2.38

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

29.4

Max

30.11

Pagrindiniai rodikliai
By Trading Economics
Pajamos	-10M -67M
Pelno marža	-7,753.425
Darbuotojai	186
EBITDA	-9.8M -73M

Rekomendacijos
By TipRanks
Rekomendacijos	Stiprus pirkimas
12 mėnesių prognozė	+86.11% upside

Dividendai
By Dow Jones
Kitas uždarbis	2026-03-04

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	111M 1.6B
Ankstesnė atidarymo kaina	32.26
Ankstesnė uždarymo kaina	29.88

Naujienos nuotaikos

By Acuity

50%

154 / 352 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Weak Bullish Evidence

18.91 / 20.63 Palaikymas ir pasipriešinimas

Celldex Therapeutics Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-03-01 23:35; UTC

Svarbiausios naujienos

Oil Prices Jump in Asia as U.S.-Iran Conflict Stokes Supply Fears -- Energy Comment

2026-03-01 23:49; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Australian Gold-Mining Stocks Rally as Attack on Iran Drives Gold Higher -- Market Talk

2026-03-01 23:47; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Gold, Silver Rise as Middle East Conflict Spurs Safe-Haven Demand -- Market Talk

2026-03-01 23:41; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Lasting Oil Price Shock Could Stoke Global Inflation -- Market Talk

2026-03-01 23:39; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Global Equities Roundup: Market Talk

2026-03-01 23:39; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Nikkei May Fall Amid Concerns About Higher Energy Prices -- Market Talk

2026-03-01 23:36; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Oil Jumps as Middle East Conflict Heightens Supply Disruption Concerns -- Market Talk

2026-03-01 23:24; UTC

Rinkos pokalbiai

Global Energy Roundup: Market Talk

2026-03-01 23:24; UTC

Rinkos pokalbiai

Financial Markets Trim Bets on RBA Hike in May -- Market Talk

2026-03-01 23:21; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2026-03-01 23:21; UTC

Rinkos pokalbiai

Sky Network TV's Risk/Reward Still Not Attractive -- Market Talk

2026-03-01 23:19; UTC

Svarbiausios naujienos

Front-Month Brent Crude Oil Futures Rose 8.5% to $79.08/bbl

2026-03-01 23:17; UTC

Svarbiausios naujienos

Front-Month WTI Crude Oil Futures Rose 8.4% to $72.65/bbl

2026-03-01 23:14; UTC

Svarbiausios naujienos

Front-Month WTI Crude Oil Futures Extend Gains in Early Trade

2026-03-01 22:55; UTC

Svarbiausios naujienos

Spot Gold Rises 1.9% to $5,278.61/oz Amid Middle East Conflict

2026-03-01 22:54; UTC

Svarbiausios naujienos

Front-Month WTI Crude Oil Futures Rise Amid Middle East Conflict

2026-03-01 22:53; UTC

Svarbiausios naujienos

Front-Month WTI Crude Oil Futures Rise 3.2% to $67.29/bbl

2026-03-01 22:38; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Attack on Iran Likely to Push Up Floor Under Gold -- Market Talk

2026-03-01 22:21; UTC

Uždarbis

Berkshire's Earnings Weren't as Bad as They Looked. A Goodwill Write-Down Hit Operating Profits. -- Barrons.com

2026-03-01 22:17; UTC

Rinkos pokalbiai

Financial Markets Trim Bets On RBA Hike In May -- Market Talk

2026-03-01 22:13; UTC

Rinkos pokalbiai

Svarbiausios naujienos

OPEC+ Oil Output Boost Could Be Moot if Strait of Hormuz Unavailable -- Market Talk

2026-03-01 22:00; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Oil Could Surge Above $100 If Flows Don't Return to Normal Quickly -- Market Talk

2026-03-01 21:40; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Spot Gold Up as Investors Shield Against Risk -- Market Talk

2026-03-01 21:35; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Oil Prices Seen Rising to Low to Mid-US$80s Per Barrel -- Market Talk

2026-03-01 21:30; UTC

Rinkos pokalbiai

Australian Dollar Weakens Most as Trader Fear Long-Term Conflict -- Market Talk

2026-03-01 21:27; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Oil Prices Likely to Rise on Iran Conflict But to Manageable Levels -- Market Talk

2026-03-01 21:19; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Shipping Disruptions 'More Acute Risk' Than Oil Output From Iran Conflict -- Market Talk

2026-03-01 20:58; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Risk Off Stance in Markets Amid Fears of Wider Conflict -- Market Talk

2026-03-01 20:40; UTC

Rinkos pokalbiai

Australia Dollar to Fall Sharply Against U.S. Dollar on Middle East Conflict -- Market Talk

2026-03-01 20:24; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Brent Crude at $100/bbl Could Slow Pace of Global Rate Cuts -- Market Talk

Akcijų palyginimas

Kainos pokytis

Celldex Therapeutics Inc Prognozė

Kainos tikslas

By TipRanks

86.11% į viršų

12 mėnesių prognozė

Vidutinis 56 USD 86.11%

Aukščiausias 90 USD

Žemiausias 24 USD

Remiantis 9 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Celldex Therapeutics Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

9 ratings

Pirkti

Laikyti

Parduoti

Remiantis 9 analitikų, pateikusių Celldex Therapeutics Inc akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Techninis įvertinimas

By Trading Central

18.91 / 20.63Palaikymas ir pasipriešinimas

Recent bullish events outweigh bearish events.

All events are bearish.

Rinkos nuotaikos

By Acuity

154 / 352 reitingas Sveikatos priežiūra

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę Celldex Therapeutics Inc

Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory, allergic, autoimmune, and other devastating diseases. The company's clinical development programs CDX-0159, a Phase II monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity. It has research collaboration and license agreements with Yale University. The company was incorporated in 1983 and is headquartered in Hampton, New Jersey.